Department of Gynaecological Oncology, Chittaranjan National Cancer Institute, Kolkata, India.
Indian J Med Res. 2009 Sep;130(3):241-6.
India with its highest share of global burden of cervical cancer has to implement a population based cervical cancer control program to reduce the number of deaths. There are new screening options available like visual inspection after acetic acid application (VIA) test, single visit approach to screening and treatment etc. Emergence of the two effective vaccines against human papillomavirus (HPV), the necessary cause of cervical cancer, has introduced a fresh lease of life to the cervical cancer control strategies. The current high cost of the vaccines is a major impediment to implement a vaccine-based primary prevention approach.
印度的宫颈癌负担在全球占比最高，因此必须实施一项基于人群的宫颈癌防控规划，以降低死亡率。目前有一些新的筛查选择，如醋酸应用后肉眼观察(VIA)检测、单次就诊的筛查和治疗等。针对宫颈癌必要病因人乳头瘤病毒（HPV）的两种有效疫苗的出现，为宫颈癌防控策略注入了新的活力。目前，疫苗价格昂贵，是实施疫苗为基础的一级预防方法的主要障碍。
